TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / July 14, 2023 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company…
Cases in Germany and the U.S. broadened by asserting additional, new intellectual property rightsThree new intellectual property rights added to…
ZTlido® profile has been viewed as a leading prescription lidocaine patch by pain specialists. Based on the independent market research…
Skye preparing to start Phase 2a glaucoma clinical trial in Q3San Diego, California--(Newsfile Corp. - July 13, 2023) - Skye…
KELOWNA, BC / ACCESSWIRE / July 13, 2023 / Tryp Therapeutics, Inc. (CSE:TRYP)(OTCQB:TRYPF) ("Tryp" or the "Company"), a clinical-stage biotechnology…
GOTHENBURG, SWEDEN / ACCESSWIRE / July 13, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) "Continued momentum for our business"Second quarter 2023…
GOTHENBURG, SE / ACCESSWIRE / July 12, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) PrimECC is a solution used to prime…
ATLANTA, GA / ACCESSWIRE / July 12, 2023 / Florence Healthcare™, a leading global provider of clinical trial site enablement…
Fiscal Year 2023 Fourth Quarter Highlights Net sales of $91.1 million increased 4.7% compared to the prior-year quarter Med Tech…
A High-throughput Protein Biomarker Discovery Platform with Proven Specificity at Any Scale Olink Explore HT Olink® Explore HT is a…